Viewing Study NCT03027349



Ignite Creation Date: 2024-05-06 @ 9:37 AM
Last Modification Date: 2024-10-26 @ 12:17 PM
Study NCT ID: NCT03027349
Status: COMPLETED
Last Update Posted: 2017-02-15
First Post: 2017-01-18

Brief Title: Serum Calcium to Phosphorous Ratio CaP as a Simple Inexpensive Screening Tool in the Diagnosis of Primary Hyperparathyroidism
Sponsor: Azienda USL Modena
Organization: Azienda USL Modena

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2017-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Background

Primary hyperparathyroidism PHPT is often overlooked and underdiagnosed At present the diagnosis of PHPT remains challenging and is based on serum calcium Ca and PTH

As serum Ca and phosphorous P are inversely related in PHPT the CaP ratio might be considered a good candidate tool in the diagnosis of PHPT

AIM The aim of this study is to investigate the diagnostic value of the CaP ratio in the diagnosis of PHPT

Study design Retrospective observational cross-sectional case-control clinical trial will be carried out

Biochemical measurements will include PTH Vitamin D serum Ca P albumin and creatinine
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None